Gynesonics designs and develops new and advanced technologies to improve women’s health. The company provides an incision-free option to treat symptomatic uterine fibroids (benign tumors on the wall of the uterus – the most common reason for hysterectomies.)

The Sonata™ system combines sonography with radio-frequency ablation to precisely locate and treat uterine fibroids – without any incisions. The system is CE mark approved in Europe andis currently enrolling patients for its US pivotal trial to evaluate safety and effectiveness.